Skip to main content
    D

    Dentsply Sirona Inc (XRAY)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $8.95
    -0.22 (-2.35%)

    Market Cap: $1.83B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Dentsply Sirona Inc (XRAY) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Dentsply Sirona (XRAY) trades at 6.6x trailing earnings and 0.5x sales. Its P/E of 6.6x is below its 5-year median of 13.5x. Its forward P/E is 7.1x. The median P/E across 9 similar companies is 28.0x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 7.0% lower over the next year. Its free cash flow yield is 5.8%.

    MultipleValue
    P/E (trailing)6.6x
    Forward P/E7.1x
    Price to sales0.5x
    Price to book1.3x
    EV/EBITDA11.1x
    Price to FCF17.3x
    EV/FCF36.8x
    PEG0.7
    FCF yield5.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 64.7% below 18.7x, its P/S is 78.3% below 2.3x and its P/B is 35.0% below 2.0x.

    MultipleCurrent5-year median10-year median
    P/E6.6x13.5x18.7x
    P/S0.5x1.5x2.3x
    P/B1.3x1.8x2.0x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 7.2x in 2025 to 29.3x in 2020. 2025 was the lowest of those years.

    Year endPriceP/EP/SP/B
    2025$11.437.2x0.6x1.7x
    2024$18.9811.4x1.0x2.0x
    2023$35.5919.4x1.9x2.3x
    2022$31.8415.3x1.7x1.8x
    2021$55.7919.4x2.9x2.4x
    2020$52.3629.3x3.4x2.3x
    2019$56.5923.1x3.1x2.5x
    2018$37.2118.5x2.1x1.6x
    2017$65.8324.7x3.8x2.3x
    2016$57.7320.8x3.4x1.7x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About XRAY

    What is XRAY's forward P/E ratio?

    Dentsply Sirona has a forward P/E ratio of 7.1x.

    Is XRAY stock overvalued?

    GNG's valuation label for XRAY is Undervalued. Its P/E of 6.6x compares with a median of 28.0x across 9 similar companies.

    What is XRAY's price to sales ratio?

    Dentsply Sirona has a price to sales ratio of 0.5x.

    What is Dentsply Sirona's average P/E ratio over 5 years?

    Dentsply Sirona's median P/E over the last 5 years is 13.5x, from 60 month-end values through Oct 2026.

    What is XRAY's PEG ratio?

    Dentsply Sirona has a PEG ratio of 0.7.